Abiopharma

ReShape Lifesciences® Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement

ReShape Lifesciences® Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement

New Form 8-K - HELIUS MEDICAL TECHNOLOGIES, INC. Filed: 2025-06-27 AccNo: 0001558370-25-008942 Size: 206 KB Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits

New Form 8-K/A - ProPhase Labs, Inc. Filed: 2025-06-27 AccNo: 0001641172-25-016815 Size: 975 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 3.02: Unregistered Sales of Equity Securities Item 9.01: …

Clearmind Medicine Expands Global Clinical Trial Targeting Multibillion-Dollar Alcohol Use Disorder Market

New Form 8-K - EASTMAN CHEMICAL CO Filed: 2025-06-27 AccNo: 0000915389-25-000136 Size: 282 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - Autolus Therapeutics plc Filed: 2025-06-27 AccNo: 0001730463-25-000046 Size: 197 KB Item 5.07: Submission of Matters to a Vote of Security Holders

Eastman Chemical Company - Eastman Board Appoints New Director

Other Scheme of Arrangement: SATISFACTION OF THE CCCS CONDITION

Omeros Submits Narsoplimab Marketing Authorization Application to the European Medicines Agency for the Treatment of TA-TMA

New Form 8-K - Alto Ingredients, Inc. Filed: 2025-06-27 AccNo: 0001213900-25-058625 Size: 187 KB Item 8.01: Other Events

Ontrak Health Announces Pricing of $4 Million Public Offering

Neurocrine Biosciences Presents New Post-Hoc Data Analyses from KINECT®-HD Study Demonstrating Significant Reduction in Disease Burden with INGREZZA® (valbenazine) Capsules for Huntingtons Disease Chorea

Results of Annual General Meeting

Helius Medical Technologies Announces Reverse Stock Split